Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

DelMar Approved to Start China Phase II Trial of Brain Cancer Treatment

publication date: Jul 24, 2017
DelMar Pharma, a Canada-US biopharma, was approved to start a China Phase II trial of its lead candidate, VAL-083, which targets glioblastoma multiforme (GBM). The trial will test VAL-083 as a first-line GBM treatment in patients with newly diagnosed MGMT-unmethylated disease. Because the trial uses a patient's MGMT status as a biomarker, it required approval from China's Human Genetic Resources Administration. DelMar is partnering new China indications for VAL-083 with Guangxi Wuzhou Pharma, which already markets the drug in China for leukemia and lung cancer. More details....

Stock Symbol: (NSDQ: DMPI)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here